tradingkey.logo
tradingkey.logo
Search

PDS Biotechnology Corp

PDSB
Add to Watchlist
0.231USD
-0.003-1.11%
Close 08-14 16:00ETQuotes delayed by 15 min
12.91MMarket Cap
LossP/E TTM

PDSB Financials

See PDS Biotechnology Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

PDS Biotechnology Corp Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-0.18/-0.13
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.74
27.92%
Analyst Rating
BUY
2026/08/16
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
14.77%-0.18
36.79%-0.13
30.90%-0.15
34.04%-0.19
9.44%-0.21
31.21%-0.21
38.37%-0.21
16.97%-0.29
39.39%-0.23
4.07%-0.30
47.77%-0.34
---0.35
---0.37
---0.32
---0.66
---0.76
----
----
----
----
Net Profit
-3.35%-9.75M
13.43%-7.35M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.60M
43.05%-10.90M
-46.13%-10.85M
-98.22%-11.53M
-14.00%-9.66M
-202.81%-19.14M
-6.66%-7.42M
-888.10%-5.82M
-177.95%-8.47M
-56.95%-6.32M
-78.22%-6.96M
Debt to assets ratio
8.19%49.55%
59.51%64.31%
15.34%55.50%
10.07%51.77%
13.65%45.80%
15.40%40.32%
19.82%48.12%
13.95%47.03%
9.52%40.30%
2.37%34.94%
33.07%40.16%
--41.28%
--36.80%
--34.13%
--30.18%
--30.78%
----
----
----
----
Operating profit
14.78%-6.50M
28.39%-6.52M
9.32%-6.67M
20.03%-8.14M
12.22%-7.62M
9.82%-9.11M
29.27%-7.36M
3.24%-10.18M
31.60%-8.68M
-7.17%-10.10M
44.71%-10.41M
-44.52%-10.52M
-79.00%-12.70M
-11.12%-9.42M
-197.73%-18.82M
-4.55%-7.28M
-38.91%-7.09M
-178.07%-8.48M
-56.96%-6.32M
-78.20%-6.96M
Net Profit
-3.35%-9.75M
13.43%-7.35M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.60M
43.05%-10.90M
-46.13%-10.85M
-98.22%-11.53M
-14.00%-9.66M
-202.81%-19.14M
-6.66%-7.42M
-888.10%-5.82M
-177.95%-8.47M
-56.95%-6.32M
-78.22%-6.96M
Current assets
-79.06%7.05M
-46.11%22.89M
-37.29%28.25M
-46.49%27.89M
-44.07%33.65M
-38.17%42.47M
-23.71%45.05M
-8.28%52.13M
-5.03%60.16M
1.05%68.69M
-22.78%59.06M
-23.62%56.84M
13.65%63.35M
11.93%67.97M
14.42%76.48M
4.30%74.41M
-27.55%55.74M
122.81%60.73M
120.32%66.84M
110.80%71.34M
Total current liabilities
7.34%12.38M
-44.45%10.15M
-44.50%9.48M
-27.32%13.33M
-26.43%11.53M
21.25%18.27M
25.36%17.09M
100.36%18.34M
98.31%15.67M
264.78%15.06M
38.78%13.63M
89.08%9.15M
75.03%7.90M
-17.71%4.13M
161.47%9.82M
35.34%4.84M
12.82%4.52M
71.34%5.02M
14.85%3.76M
23.41%3.58M
Total assets
-78.24%8.81M
-47.56%24.66M
-32.77%30.49M
-33.83%34.71M
-33.09%40.48M
-31.85%47.03M
-23.63%45.36M
-8.28%52.45M
-5.11%60.50M
0.81%69.01M
-22.88%59.39M
-23.63%57.19M
13.85%63.75M
12.14%68.45M
14.60%77.01M
4.37%74.89M
-27.64%56.00M
119.87%61.04M
117.54%67.20M
108.30%71.75M
Total liabilities
-49.47%12.39M
-15.79%20.77M
-19.40%21.24M
-17.07%25.25M
-17.11%24.52M
-22.49%24.67M
-20.76%26.35M
-6.89%30.45M
-5.53%29.58M
15.98%31.82M
0.77%33.26M
17.52%32.70M
584.29%31.31M
431.17%27.44M
727.74%33.01M
615.16%27.83M
4.03%4.58M
52.49%5.17M
6.03%3.99M
13.77%3.89M
Total equity
-122.43%-3.58M
-82.59%3.89M
-51.32%9.25M
-57.03%9.45M
-48.38%15.96M
-39.86%22.36M
-27.27%19.00M
-10.14%22.00M
-4.70%30.92M
-9.33%37.18M
-40.61%26.13M
-47.97%24.48M
-36.91%32.44M
-26.60%41.01M
-30.39%44.00M
-30.65%47.06M
-29.55%51.43M
129.23%55.87M
132.99%63.21M
118.72%67.86M
Net operating income
69.32%-2.79M
51.60%-4.37M
55.04%-3.70M
26.05%-5.92M
-2.75%-9.10M
9.12%-9.03M
2.63%-8.23M
-11.48%-8.00M
-83.99%-8.86M
24.65%-9.94M
-12.33%-8.46M
-21.77%-7.18M
18.66%-4.81M
-107.08%-13.19M
-67.26%-7.53M
-14.90%-5.89M
-725.52%-5.92M
-67.51%-6.37M
2.76%-4.50M
-309.62%-5.13M
Net investment
----
----
--0.00
100.00%0.00
----
----
--0.00
---1.00
---29.00K
----
----
----
----
----
----
----
----
----
----
----
Net financing
-1432.58%-13.27M
-109.29%-679.83K
2340.07%4.22M
1301.05%241.21K
7324.31%995.94K
-63.42%7.32M
-98.40%172.78K
-97.85%17.22K
-105.74%-13.79K
338.11%20.01M
10.92%10.77M
-96.73%802.33K
970.07%240.01K
60902.34%4.57M
74666484.62%9.71M
19777.64%24.55M
-99.95%22.43K
--7.49K
--13.00
-99.31%123.51K

FAQs

What are the current assets of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its current assets were 28.25M, with a year-on-year change of -37.29.

What are the total assets of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its total assets of PDS Biotechnology Corp were 30.49M, with a year-on-year change of -32.77.

What are the total liabilities of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its total liabilities of PDS Biotechnology Corp were 21.24M, with a year-on-year change of -19.40.

What is the total equity of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its total equity of PDS Biotechnology Corp was 9.25M, with a year-on-year change of -51.32.

What is the net operating income of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its net operating income of PDS Biotechnology Corp was -31.54M, with a year-on-year change of 13.15.

What is the net financing of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its net financing of PDS Biotechnology Corp was 12.77M, with a year-on-year change of -36.72.

What is the Earnings Per Share (EPS) of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.74, with a year-on-year change of 27.92.

What is the net income of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its net income was -34.50M, with a year-on-year change of 8.28.

What is the debt-to-asset ratio of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its debt-to-asset ratio was 55.50, with a year-on-year change of 15.34.

What is the Return on Equity (ROE) of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its Return on Equity (ROE) was -244.16, with a year-on-year change of -46.51.

What is the Return on Assets (ROA) of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its Return on Assets (ROA) was -90.95, with a year-on-year change of -26.66.

What is the operating profit of PDS Biotechnology Corp?

According to PDS Biotechnology Corp's FY2025 earnings report, its operating profit was -31.54M, with a year-on-year change of 13.15.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.